Ranitidine Tablet
Product Images NDC 71993-314

4 FDA label images from Atland Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 71993-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atland Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

"image Description" (Ranitidine Tabs 150mg 30s Bottle Label)

"image Description" (Ranitidine Tabs 150mg 30s Bottle Label)
Ranitidine Tablets USP 150 mg oral tablet label from Atland Pharmaceuticals, LLC. Contains 30 tablets with a 3-month use period after opening. Includes storage instructions, warning about FD&C Yellow No. 6 additive, and meets FDA specifications for nitrosamine impurities. Distributed by Atland Pharmaceuticals and manufactured by VKT Pharma, India. Features barcode and placeholder area labeled NVZ Area.*
FDA Label Image

"image Description" (Ranitidine Tabs 300mg 30s Bottle Label)

"image Description" (Ranitidine Tabs 300mg 30s Bottle Label)
Ranitidine Tablets, USP 300 mg oral tablets label by Atland Pharmaceuticals, LLC. The label includes dosage strength, storage instructions (15°C to 30°C), a warning about FD&C Yellow No. 5 color additive, use within 3 months (90 days) after bottle opening, and discard instructions. It states the product meets FDA specifications for nitrosamine impurities. The bottle contains 30 tablets and is prescription-only, distributed by Atland Pharmaceuticals, manufactured by VKT Pharma in India. A barcode is present on the right side.*
FDA Label Image

"image Description" (Ranitidine Tabs Structure)

"image Description" (Ranitidine Tabs Structure)
Chemical structure diagram of ranitidine, the active ingredient in the product. The molecular structure depicts atoms and bonds characteristic of ranitidine's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.